The failure of torcetrapib: is there a case for independent preclinical and clinical testing?--correspondence
Expert Opin Pharmacother
.
2008 Oct;9(14):2561-2; author reply 2563-4.
doi: 10.1517/14656566.9.14.2561.
Author
Charles L Shear
PMID:
18778194
DOI:
10.1517/14656566.9.14.2561
No abstract available
Publication types
Comment
Letter
MeSH terms
Anticholesteremic Agents / therapeutic use*
Clinical Trials as Topic
Humans
Quinolines / therapeutic use*
Research Design
Treatment Outcome
Substances
Anticholesteremic Agents
Quinolines
torcetrapib